157 related articles for article (PubMed ID: 35034624)
21. The impact of somatic SMAD4 mutations in colorectal liver metastases.
Xourafas D; Mizuno T; Cloyd JM
Chin Clin Oncol; 2019 Oct; 8(5):52. PubMed ID: 31500428
[TBL] [Abstract][Full Text] [Related]
22. miR-19b-3p promotes colon cancer proliferation and oxaliplatin-based chemoresistance by targeting SMAD4: validation by bioinformatics and experimental analyses.
Jiang T; Ye L; Han Z; Liu Y; Yang Y; Peng Z; Fan J
J Exp Clin Cancer Res; 2017 Sep; 36(1):131. PubMed ID: 28938919
[TBL] [Abstract][Full Text] [Related]
23. Smad4 regulates claudin-1 expression in a transforming growth factor-beta-independent manner in colon cancer cells.
Shiou SR; Singh AB; Moorthy K; Datta PK; Washington MK; Beauchamp RD; Dhawan P
Cancer Res; 2007 Feb; 67(4):1571-9. PubMed ID: 17308096
[TBL] [Abstract][Full Text] [Related]
24. Circulating long non-coding RNA colon cancer-associated transcript 2 protected by exosome as a potential biomarker for colorectal cancer.
Wang L; Duan W; Yan S; Xie Y; Wang C
Biomed Pharmacother; 2019 May; 113():108758. PubMed ID: 30877883
[TBL] [Abstract][Full Text] [Related]
25. miR-224 Controls Human Colorectal Cancer Cell Line HCT116 Proliferation by Targeting Smad4.
Zhou J; Hu M; Wang F; Song M; Huang Q; Ge B
Int J Med Sci; 2017; 14(10):937-942. PubMed ID: 28924364
[No Abstract] [Full Text] [Related]
26.
Sheng S; Xie L; Wu Y; Ding M; Zhang T; Wang X
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30745456
[TBL] [Abstract][Full Text] [Related]
27. miR‑20a is an independent prognostic factor in colorectal cancer and is involved in cell metastasis.
Zhang GJ; Li Y; Zhou H; Xiao HX; Zhou T
Mol Med Rep; 2014 Jul; 10(1):283-91. PubMed ID: 24737193
[TBL] [Abstract][Full Text] [Related]
28. Usefulness of plasma epigenetic changes of five major genes involved in the pathogenesis of colorectal cancer.
Pack SC; Kim HR; Lim SW; Kim HY; Ko JY; Lee KS; Hwang D; Park SI; Kang H; Park SW; Hong GY; Hwang SM; Shin MG; Lee S
Int J Colorectal Dis; 2013 Jan; 28(1):139-47. PubMed ID: 22990173
[TBL] [Abstract][Full Text] [Related]
29. Tumor suppressor microRNA-31 inhibits gastric carcinogenesis by targeting Smad4 and SGPP2.
Ruoming W; Zhen Y; Tengteng Z; Jisheng H
Cancer Gene Ther; 2015 Dec; 22(12):564-72. PubMed ID: 26494556
[TBL] [Abstract][Full Text] [Related]
30. Promoter methylation correlates with reduced Smad4 expression in advanced prostate cancer.
Aitchison AA; Veerakumarasivam A; Vias M; Kumar R; Hamdy FC; Neal DE; Mills IG
Prostate; 2008 May; 68(6):661-74. PubMed ID: 18213629
[TBL] [Abstract][Full Text] [Related]
31. Bromodomain and extra-terminal motif (BET) inhibition is synthetic lethal with loss of SMAD4 in colorectal cancer cells via restoring the loss of MYC repression.
Shi C; Yang EJ; Liu Y; Mou PK; Ren G; Shim JS
Oncogene; 2021 Feb; 40(5):937-950. PubMed ID: 33293694
[TBL] [Abstract][Full Text] [Related]
32. miR-34a mediates oxaliplatin resistance of colorectal cancer cells by inhibiting macroautophagy
Sun C; Wang FJ; Zhang HG; Xu XZ; Jia RC; Yao L; Qiao PF
World J Gastroenterol; 2017 Mar; 23(10):1816-1827. PubMed ID: 28348487
[TBL] [Abstract][Full Text] [Related]
33. Genome-wide CRISPR Screen Reveals RAB10 as a Synthetic Lethal Gene in Colorectal and Pancreatic Cancers Carrying SMAD4 Loss.
Erasimus H; Kolnik V; Lacroix F; Sidhu S; D'Agostino S; Lemaitre O; Rohaut A; Sanchez I; Thill G; Didier M; Debussche L; Marcireau C
Cancer Res Commun; 2023 May; 3(5):780-792. PubMed ID: 37377893
[TBL] [Abstract][Full Text] [Related]
34. Distinguishing between cancer driver and passenger gene alteration candidates via cross-species comparison: a pilot study.
Ji X; Tang J; Halberg R; Busam D; Ferriera S; Peña MM; Venkataramu C; Yeatman TJ; Zhao S
BMC Cancer; 2010 Aug; 10():426. PubMed ID: 20707908
[TBL] [Abstract][Full Text] [Related]
35. The role of SMAD4 in early-onset colorectal cancer.
Royce SG; Alsop K; Haydon A; Mead L; Smith LD; Tesoriero AA; Giles GG; Jenkins MA; Hopper JL; Southey MC
Colorectal Dis; 2010 Mar; 12(3):213-9. PubMed ID: 19183329
[TBL] [Abstract][Full Text] [Related]
36. SMAD2, SMAD3 and SMAD4 mutations in colorectal cancer.
Fleming NI; Jorissen RN; Mouradov D; Christie M; Sakthianandeswaren A; Palmieri M; Day F; Li S; Tsui C; Lipton L; Desai J; Jones IT; McLaughlin S; Ward RL; Hawkins NJ; Ruszkiewicz AR; Moore J; Zhu HJ; Mariadason JM; Burgess AW; Busam D; Zhao Q; Strausberg RL; Gibbs P; Sieber OM
Cancer Res; 2013 Jan; 73(2):725-35. PubMed ID: 23139211
[TBL] [Abstract][Full Text] [Related]
37. A novel transcript, VNN1-AB, as a biomarker for colorectal cancer.
Løvf M; Nome T; Bruun J; Eknaes M; Bakken AC; Mpindi JP; Kilpinen S; Rognum TO; Nesbakken A; Kallioniemi O; Lothe RA; Skotheim RI
Int J Cancer; 2014 Nov; 135(9):2077-84. PubMed ID: 24687856
[TBL] [Abstract][Full Text] [Related]
38. Smad4 sensitizes colorectal cancer to 5-fluorouracil through cell cycle arrest by inhibiting the PI3K/Akt/CDC2/survivin cascade.
Zhang B; Leng C; Wu C; Zhang Z; Dou L; Luo X; Zhang B; Chen X
Oncol Rep; 2016 Mar; 35(3):1807-15. PubMed ID: 26647806
[TBL] [Abstract][Full Text] [Related]
39. DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer.
Kalmár A; Péterfia B; Hollósi P; Galamb O; Spisák S; Wichmann B; Bodor A; Tóth K; Patai ÁV; Valcz G; Nagy ZB; Kubák V; Tulassay Z; Kovalszky I; Molnár B
BMC Cancer; 2015 Oct; 15():736. PubMed ID: 26482433
[TBL] [Abstract][Full Text] [Related]
40. Analysis of SMAD4/DPC4 gene alterations in multiploid colorectal carcinomas.
Ando T; Sugai T; Habano W; Jiao YF; Suzuki K
J Gastroenterol; 2005 Jul; 40(7):708-15. PubMed ID: 16082587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
